DYN
Price
$8.80
Change
-$0.08 (-0.90%)
Updated
Jul 10 closing price
Capitalization
1.26B
20 days until earnings call
MRSN
Price
$0.38
Change
+$0.04 (+11.76%)
Updated
Jul 10 closing price
Capitalization
42.03M
26 days until earnings call
Interact to see
Advertisement

DYN vs MRSN

Header iconDYN vs MRSN Comparison
Open Charts DYN vs MRSNBanner chart's image
Dyne Therapeutics
Price$8.80
Change-$0.08 (-0.90%)
Volume$3.01M
Capitalization1.26B
Mersana Therapeutics
Price$0.38
Change+$0.04 (+11.76%)
Volume$6.37M
Capitalization42.03M
DYN vs MRSN Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. MRSN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and MRSN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (DYN: $8.80 vs. MRSN: $0.38)
Brand notoriety: DYN and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 102% vs. MRSN: 212%
Market capitalization -- DYN: $1.26B vs. MRSN: $42.03M
DYN [@Biotechnology] is valued at $1.26B. MRSN’s [@Biotechnology] market capitalization is $42.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while MRSN’s TA Score has 6 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 5 bearish.
  • MRSN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +0.46% price change this week, while MRSN (@Biotechnology) price change was +31.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

DYN is expected to report earnings on Oct 30, 2025.

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.26B) has a higher market cap than MRSN($42M). DYN YTD gains are higher at: -62.649 vs. MRSN (-73.427). MRSN has higher annual earnings (EBITDA): -68.42M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. MRSN (102M). DYN has less debt than MRSN: DYN (23.3M) vs MRSN (24.6M). MRSN has higher revenues than DYN: MRSN (34M) vs DYN (0).
DYNMRSNDYN / MRSN
Capitalization1.26B42M2,993%
EBITDA-395.31M-68.42M578%
Gain YTD-62.649-73.42785%
P/E RatioN/AN/A-
Revenue034M-
Total Cash677M102M664%
Total Debt23.3M24.6M95%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNMRSN
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEYS33.730.65
+1.96%
Weyco Group
IESC310.305.94
+1.95%
IES Holdings
GS709.1212.56
+1.80%
Goldman Sachs Group
GIII23.750.20
+0.85%
G-III Apparel Group Ltd
DRIO0.72N/A
-0.36%
DarioHealth Corp

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-0.90%
RNA - DYN
56%
Loosely correlated
+0.64%
CRNX - DYN
55%
Loosely correlated
-1.05%
XNCR - DYN
52%
Loosely correlated
-0.54%
SYRE - DYN
51%
Loosely correlated
-3.56%
RVMD - DYN
50%
Loosely correlated
-0.05%
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+12.69%
IGMS - MRSN
54%
Loosely correlated
+0.74%
CRNX - MRSN
48%
Loosely correlated
-1.05%
DYN - MRSN
47%
Loosely correlated
-0.90%
DNLI - MRSN
42%
Loosely correlated
+2.33%
RGNX - MRSN
41%
Loosely correlated
-1.20%
More